RSV F Dose-Ranging Study in Women
Public ClinicalTrials.gov record NCT01960686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the immunogenicity and safety of multiple formulations of an RSV-F protein nanoparticle vaccine, with aluminum, in healthy women of child-bearing age.
Study identification
- NCT ID
- NCT01960686
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 720 participants
Conditions and interventions
Conditions
Interventions
- Low dose RSV F Antigen Biological
- High dose RSV F Antigen Biological
- Dose 1 of Aluminum Adjuvant Biological
- Dose 2 of Aluminum Adjuvant Biological
- Dose 3 of Aluminum Adjuvant Biological
- Dose 4 of Aluminum Adjuvant Biological
- Placebo Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 35 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2013
- Primary completion
- Mar 31, 2014
- Completion
- Mar 31, 2014
- Last update posted
- May 25, 2016
2013 – 2014
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Diablo Clinical Research | Walnut Creek | California | 94598 | — |
| Clincal Research of Atlanta | Stockbridge | Georgia | 30281 | — |
| Advanced Clinical Research | Boise | Idaho | 83642 | — |
| Johnson County Clin-Trials | Lenexa | Kansas | 66219 | — |
| QPS Bio-Kinetic | Springfield | Missouri | 65802 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Coastal Carolina Research | Mt. Pleasant | South Carolina | 29464 | — |
| Research Across America | Dallas | Texas | 75234 | — |
| Clinical Trials of Texas | San Antonio | Texas | 78229 | — |
| Jean Brown Research | Salt Lake City | Utah | 84124 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01960686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 25, 2016 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01960686 live on ClinicalTrials.gov.